巴黎系统发布前尿液细胞病理学实践模式调查
该研究于2014年7月向参与美国病理学家学会室间比对计划的2116家实验室发放问卷,评估尿液细胞病理学实践模式。879家(41%)参与,745家(84.8%)在室内处理尿液标本;最常用制片方法为ThinPrep(57.4%)和Cytospin(45.5%);41.7%的实验室对自然排尿尿使用 adequacy 标准;超过95%使用阴性、非典型、可疑、阳性四级分类;63.6%将多瘤病毒归类为阴性。结论建议巴黎系统标准需在Cytospin上验证。
要点
- 多数实验室使用ThinPrep和Cytospin制片,巴黎系统标准需在Cytospin上验证。
- 仅41.7%实验室对自然排尿尿使用 adequacy 标准,34.5%对膀胱冲洗液评估 adequacy。
- 超过95%实验室采用阴性、非典型、可疑、阳性四级报告分类。
核心结论
- 多数实验室使用ThinPrep后Cytospin技术,巴黎系统标准应验证Cytospin并纳入修订版。
研究设计与样本
- 2014年7月向参与美国病理学家学会室间比对计划的2116家实验室邮寄问卷,879家(41%)参与。
主要发现
- 745/879家(84.8%)在室内处理尿液标本。
- 自然排尿尿处理率99.6%(735/738),膀胱冲洗/刷洗86.6%(639/738),导尿88.5%(653/738)。
- 最常用制片技术为ThinPrep(57.4%)和Cytospin(45.5%)。
- 41.7%(295/707)对自然排尿尿使用 adequacy 标准,34.5%(244/707)对膀胱冲洗/刷洗评估 adequacy。
- 超过95%实验室使用阴性、非典型、可疑、阳性分类;多瘤病毒归类为阴性者63.6%(408/642),非典型者29.4%(189/642)。
关键数值与推荐
- 细胞块制备率44.7%(88/197),但频率低。
临床怎么用
- 实验室应关注Cytospin制片下巴黎系统标准的适用性验证。
- 可参考多数实验室的四级分类报告尿液细胞学。
局限性
- 问卷邮寄于2014年7月,可能未反映巴黎系统后续推广后的实践变化。
- 参与率41%,存在无应答偏倚可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT.—: The Paris System for Reporting Urinary Cytology has been disseminated since its inception in 2013; however, the daily practice patterns of urinary tract cytopathology are not well known. OBJECTIVE.—: To assess urinary tract cytopathology practice patterns across a variety of pathology laboratories to aid in the implementation and future update of the Paris System for Reporting Urinary Cytology. DESIGN.—: A questionnaire was designed to gather information about urinary tract cytopathology practices and mailed in July 2014 to 2116 laboratories participating in the College of American Pathologists interlaboratory comparison program. The participating laboratories' answers were summarized. RESULTS.—: Of the 879 of 2116 laboratories (41%) that participated, 745 (84.8%) reported processing urinary tract specimens in house. The laboratories reported processing various specimen types: voided urine, 735 of 738 (99.6%); bladder washing/barbotage, 639 of 738 (86.6%); and catheterized urine specimens, 653 of 738 (88.5%). Some laboratories used multiple preparation methods, but the most commonly used preparation techniques for urinary tract specimens were ThinPrep (57.4%) and Cytospin (45.5%). Eighty-eight of 197 laboratories (44.7%) reported preparing a cell block, but with a low frequency. Adequacy criteria were used by 295 of 707 laboratories (41.7%) for voided urine, and 244 of 707 (34.5%) assessed adequacy for bladder washing/barbotage. More than 95% of the laboratories reported the use of general categories: negative, atypical, suspicious, and positive. Polyomavirus was classified as negative in 408 of 642 laboratories (63.6%) and atypical in 189 of 642 (29.4%). One hundred twenty-eight of 708 laboratories (18.1%) performed ancillary testing, and of these, 102 of 122 (83.6%) reported performing UroVysion. CONCLUSIONS.—: Most laboratories use the ThinPrep method followed by the Cytospin technique; therefore, the criteria published in The Paris System for Reporting Urinary Cytology, based mostly on ThinPrep and SurePath, should be validated for Cytospin, and relevant information should be included in the revised edition of The Paris System for Reporting Urinary Cytology.
引用
- Barkan GA, Tabatabai ZL, Kurtycz DFI, et al. Practice Patterns in Urinary Cytopathology Prior to the Paris System for Reporting Urinary Cytology. Arch Pathol Lab Med. 2019. PMID: 31295017. doi:10.5858/arpa.2019-0045-CP
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。